Search Results 931-940 of 18495 for prednisone

1. Rifampin (oral route) - Side effects & dosage - Mayo Clinic

   Prednisone; Raltegravir; Repaglinide; Rofecoxib; Sertraline; Triazolam; Trimetrexate; Valproic Acid; Zaleplon. Other Interactions. Certain medicines should not ...

2. Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19 (enrollment by invitation only) - Mayo Clinic

   Use of chronic oral corticosteroids for a non-COVID-19-related condition in a dose higher than prednisone 10 mg or equivalent per day; History of, or current ...

3. A Study to Evaluate Effectiveness of 2 Doses of Oral CXA-10 in Pulmonary Arterial Hypertension (PAH) - Mayo Clinic

   Received prednisone doses >15mg/day or changes in immunosuppressive medications < 12 weeks prior to Screening (Visit 1); Recent (within 1 year) history of ...

4. Efficacy and Safety Study of Benralizumab to Reduce OCS Use in Patients With Uncontrolled Asthma on High Dose Inhaled Corticosteroid Plus LABA and Chronic OCS Therapy - Mayo Clinic

   Chronic oral prednisone or prednisolone therapy for at least 6 continuous months directly preceding Visit 1, and on a stable dose for at least one month prior ...

5. Ibrutinib in Treating Minimal Residual Disease in Patients With Chronic Lymphocytic Leukemia After Front-Line Therapy - Mayo Clinic

   NOTE: Patients on low dose prednisone (=< 10 mg) for treatment of conditions other than CLL are eligible. Patients who have received more than 1 prior ...

6. Biomarker for Skeletal Loading Using Triaxial Accelerometers - Mayo Clinic

   ... prednisone; Moderate to severe hip or knee arthritis; Self-reported medical conditions that could affect the skeletal system such as diabetes or other ...

7. A Study of Adjunctive Ganaxolone Treatment in Children and Young Adults with CDKL5 Deficiency Disorder - Mayo Clinic

   Patients on ACTH, prednisone or other systemically (non-inhaled) administered steroids should be off the product greater than 28 days prior to screening.

8. Nivolumab and Ipilimumab in Treating Patients With Esophageal and Gastroesophageal Junction Adenocarcinoma Undergoing Surgery - Mayo Clinic

   Inhaled or topical steroids and adrenal replacement doses =< 10 mg/day prednisone equivalents are permitted in the absence of active autoimmune disease.

9. A Study to Evaluate the Immune Response to Anti-HER2 Therapies - Mayo Clinic

   NOTE: Inhaled steroids, low-dose corticosteroids (e.g., equivalent to or less than oral prednisone 10 mg daily), and steroid use for primary prevention of ...

10. TransCon (TC) TLR7/​8 Agonist, TC IL-2 β/​γ, Pembrolizumab Prior to Surgery for Advanced Head and Neck Squamous Cell Carcinoma (BelieveIT-201) - Mayo Clinic

    exceeding 10 mg daily of prednisone equivalent) or any other form of immunosuppressive therapy within 7 days prior to randomization. Note: Other protocol ...